Abstract | Background: Methods: We investigated the behavior of mice with a conventional or conditional deletion of Scn2a in a comprehensive test battery including open field, elevated plus maze, light-dark box, three chambers, social dominance tube, resident-intruder, ultrasonic vocalization, and fear conditioning tests. We further monitored the effects of the positive allosteric modulator of AMPA receptors CX516 on these model mice. Results: Conventional heterozygous Scn2a knockout mice (Scn2aKO/+) displayed novelty-induced exploratory hyperactivity and increased rearing. The increased vertical activity was reproduced by heterozygous inactivation of Scn2a in dorsal-telencephalic excitatory neurons but not in inhibitory neurons. Moreover, these phenotypes were rescued by treating Scn2aKO/+ mice with CX516. Additionally, Scn2aKO/+ mice displayed mild social behavior impairment, enhanced fear conditioning, and deficient fear extinction. Neuronal activity was intensified in the medial prefrontal cortex of Scn2aKO/+ mice, with an increase in the gamma band. Conclusions: Scn2aKO/+ mice exhibit a spectrum of phenotypes commonly observed in models of schizophrenia and autism spectrum disorder. Treatment with the CX516 ampakine, which ameliorates hyperactivity in these mice, could be a potential therapeutic strategy to rescue some of the disease phenotypes.
|
Authors | Tetsuya Tatsukawa, Matthieu Raveau, Ikuo Ogiwara, Satoko Hattori, Hiroyuki Miyamoto, Emi Mazaki, Shigeyoshi Itohara, Tsuyoshi Miyakawa, Mauricio Montal, Kazuhiro Yamakawa |
Journal | Molecular autism
(Mol Autism)
Vol. 10
Pg. 15
( 2019)
ISSN: 2040-2392 [Electronic] England |
PMID | 30962870
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 1-(quinoxalin-6-ylcarbonyl)piperidine
- Dioxoles
- Membrane Transport Modulators
- NAV1.2 Voltage-Gated Sodium Channel
- Piperidines
|
Topics |
- Animals
- Anxiety
(drug therapy, genetics)
- Autism Spectrum Disorder
(drug therapy, genetics)
- Dioxoles
(therapeutic use)
- Gamma Rhythm
- Haploinsufficiency
- Male
- Membrane Transport Modulators
(therapeutic use)
- Memory
- Mice
- Mice, Inbred C57BL
- NAV1.2 Voltage-Gated Sodium Channel
(genetics)
- Phenotype
- Piperidines
(therapeutic use)
- Prefrontal Cortex
(drug effects, physiopathology)
- Psychomotor Agitation
(drug therapy, genetics)
- Social Behavior
|